Drug Profile
Anti-CD40L antibody - Bristol-Myers Squibb
Alternative Names: Anti-CD40L antibody -Bristol-Myers SquibbLatest Information Update: 18 Oct 2016
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Monoclonal antibodies
- Mechanism of Action CD40 ligand inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Immunological disorders
Most Recent Events
- 18 Oct 2016 Phase-II clinical trials in Immunological disorders in USA (Parenteral)